CN103719498B - 一种提高免疫力的黄精保健茶及其制备方法 - Google Patents
一种提高免疫力的黄精保健茶及其制备方法 Download PDFInfo
- Publication number
- CN103719498B CN103719498B CN201310753121.9A CN201310753121A CN103719498B CN 103719498 B CN103719498 B CN 103719498B CN 201310753121 A CN201310753121 A CN 201310753121A CN 103719498 B CN103719498 B CN 103719498B
- Authority
- CN
- China
- Prior art keywords
- parts
- immunity
- sealwort
- fruit
- solomonseal rhizome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000036039 immunity Effects 0.000 title claims abstract description 64
- 241000756042 Polygonatum Species 0.000 title claims abstract description 43
- 235000008737 Polygonatum biflorum Nutrition 0.000 title claims abstract description 38
- 241001122767 Theaceae Species 0.000 title claims description 46
- 238000002360 preparation method Methods 0.000 title claims description 16
- 239000003814 drug Substances 0.000 claims abstract description 68
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 46
- 230000036541 health Effects 0.000 claims abstract description 22
- 241001165494 Rhodiola Species 0.000 claims abstract description 20
- 244000197580 Poria cocos Species 0.000 claims abstract description 18
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 18
- 241000756943 Codonopsis Species 0.000 claims abstract description 17
- 239000009636 Huang Qi Substances 0.000 claims abstract description 17
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 17
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 16
- 244000241872 Lycium chinense Species 0.000 claims abstract description 16
- 241000218231 Moraceae Species 0.000 claims abstract description 16
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 241001523681 Dendrobium Species 0.000 claims abstract description 14
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 14
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 13
- 230000001976 improved effect Effects 0.000 claims abstract description 8
- 235000013616 tea Nutrition 0.000 claims description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- 229940079593 drug Drugs 0.000 claims description 27
- 239000000284 extract Substances 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 230000008901 benefit Effects 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 20
- 241000736199 Paeonia Species 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 5
- 238000007493 shaping process Methods 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 4
- 230000008030 elimination Effects 0.000 claims description 4
- 238000003379 elimination reaction Methods 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 238000005057 refrigeration Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000000967 suction filtration Methods 0.000 claims description 3
- 235000015091 medicinal tea Nutrition 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 50
- 210000004369 blood Anatomy 0.000 abstract description 48
- 210000000952 spleen Anatomy 0.000 abstract description 44
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 30
- 230000007812 deficiency Effects 0.000 abstract description 26
- 210000003734 kidney Anatomy 0.000 abstract description 24
- 210000004072 lung Anatomy 0.000 abstract description 24
- 230000035922 thirst Effects 0.000 abstract description 16
- 210000003127 knee Anatomy 0.000 abstract description 11
- 238000010791 quenching Methods 0.000 abstract description 11
- 206010049865 Achromotrichia acquired Diseases 0.000 abstract description 10
- 239000000203 mixture Substances 0.000 abstract description 10
- 208000009205 Tinnitus Diseases 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 9
- 231100000886 tinnitus Toxicity 0.000 abstract description 9
- 239000011800 void material Substances 0.000 abstract description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 6
- 150000002632 lipids Chemical class 0.000 abstract description 6
- 230000001603 reducing effect Effects 0.000 abstract description 6
- 230000009467 reduction Effects 0.000 abstract description 6
- 208000001953 Hypotension Diseases 0.000 abstract description 5
- 206010043866 Tinea capitis Diseases 0.000 abstract description 5
- 208000021822 hypotensive Diseases 0.000 abstract description 5
- 230000001077 hypotensive effect Effects 0.000 abstract description 5
- 201000001881 impotence Diseases 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 5
- 208000009189 tinea favosa Diseases 0.000 abstract description 5
- 235000016508 Polygonatum biflorum var. biflorum Nutrition 0.000 abstract description 3
- 235000012000 cholesterol Nutrition 0.000 abstract description 3
- 230000003860 sleep quality Effects 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 3
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 47
- 241000699666 Mus <mouse, genus> Species 0.000 description 37
- 201000010099 disease Diseases 0.000 description 25
- 230000006870 function Effects 0.000 description 17
- 150000004676 glycans Chemical class 0.000 description 16
- 229920001282 polysaccharide Polymers 0.000 description 16
- 239000005017 polysaccharide Substances 0.000 description 16
- 206010011224 Cough Diseases 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 210000000056 organ Anatomy 0.000 description 13
- 230000000242 pagocytic effect Effects 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 208000033065 inborn errors of immunity Diseases 0.000 description 10
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 10
- 238000011160 research Methods 0.000 description 10
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- 238000003304 gavage Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 206010037660 Pyrexia Diseases 0.000 description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 208000002173 dizziness Diseases 0.000 description 8
- 206010022437 insomnia Diseases 0.000 description 8
- 210000002540 macrophage Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 230000013016 learning Effects 0.000 description 7
- 210000001541 thymus gland Anatomy 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 6
- 210000000987 immune system Anatomy 0.000 description 6
- 244000000010 microbial pathogen Species 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- 230000000306 recurrent effect Effects 0.000 description 6
- 230000002269 spontaneous effect Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- ZOOGRGPOEVQQDX-KHLHZJAASA-N cyclic guanosine monophosphate Chemical compound C([C@H]1O2)O[P@](O)(=O)O[C@@H]1[C@H](O)[C@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-KHLHZJAASA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 240000004638 Dendrobium nobile Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 235000003713 Rhodiola rosea Nutrition 0.000 description 4
- 244000042430 Rhodiola rosea Species 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 210000003024 peritoneal macrophage Anatomy 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 150000005856 steroid saponins Chemical class 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 108010082126 Alanine transaminase Proteins 0.000 description 3
- 101710088194 Dehydrogenase Proteins 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 206010027339 Menstruation irregular Diseases 0.000 description 3
- 206010057249 Phagocytosis Diseases 0.000 description 3
- 241000037831 Polygonatum sibiricum Species 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 206010046788 Uterine haemorrhage Diseases 0.000 description 3
- 240000008866 Ziziphus nummularia Species 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- 239000006196 drop Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 238000010172 mouse model Methods 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000008782 phagocytosis Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 208000019116 sleep disease Diseases 0.000 description 3
- 208000020685 sleep-wake disease Diseases 0.000 description 3
- 235000015096 spirit Nutrition 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 240000002624 Mespilus germanica Species 0.000 description 2
- 235000017784 Mespilus germanica Nutrition 0.000 description 2
- 235000000560 Mimusops elengi Nutrition 0.000 description 2
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 2
- 244000236658 Paeonia lactiflora Species 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 235000007837 Vangueria infausta Nutrition 0.000 description 2
- 201000004810 Vascular dementia Diseases 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001147 anti-toxic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- -1 lignanoid Chemical class 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 231100000682 maximum tolerated dose Toxicity 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000003446 memory effect Effects 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 235000021179 potluck Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- JVXZRQGOGOXCEC-UHFFFAOYSA-N scutellarein Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(O)=C(O)C=C2O1 JVXZRQGOGOXCEC-UHFFFAOYSA-N 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 240000007185 Albizia julibrissin Species 0.000 description 1
- 235000011468 Albizia julibrissin Nutrition 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241000007126 Codonopsis pilosula Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000759833 Cornus officinalis Species 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- 241000110637 Cuscuta chinensis Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 241000026010 Dendrobium candidum Species 0.000 description 1
- 244000269590 Dendrobium chrysanthum Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 244000286838 Eclipta prostrata Species 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002306 Glycocalyx Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- 208000001688 Herpes Genitalis Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000037826 Polygonatum kingianum Species 0.000 description 1
- 244000292697 Polygonum aviculare Species 0.000 description 1
- 235000006386 Polygonum aviculare Nutrition 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000019155 Radiation injury Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 235000014327 Sedum acre Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 231100000439 acute liver injury Toxicity 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000002115 aflatoxin B1 Substances 0.000 description 1
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 description 1
- 229930020125 aflatoxin-B1 Natural products 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 201000004946 genital herpes Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 210000004517 glycocalyx Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000437 hepatocellular injury Toxicity 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000009863 impact test Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000003526 lymphopoietic effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000003726 plant lectin Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000000191 radiation effect Effects 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 238000002910 structure generation Methods 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 150000003557 thiazoles Chemical class 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 102000014898 transaminase activity proteins Human genes 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 小鼠(只) | 胸腺指数 | 脾指数 |
空白对照组 | 12 | 8.32±0.37 | 7.35±0.43 |
CTX对照组 | 12 | 4.26±0.17Δ | 4.35±0.23Δ |
高剂量组 | 12 | 6.34±0.27** | 5.82±0.25** |
低剂量组 | 12 | 5.72±0.23** | 4.65±0.16* |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310753121.9A CN103719498B (zh) | 2013-12-31 | 2013-12-31 | 一种提高免疫力的黄精保健茶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310753121.9A CN103719498B (zh) | 2013-12-31 | 2013-12-31 | 一种提高免疫力的黄精保健茶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103719498A CN103719498A (zh) | 2014-04-16 |
CN103719498B true CN103719498B (zh) | 2015-12-09 |
Family
ID=50443992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310753121.9A Active CN103719498B (zh) | 2013-12-31 | 2013-12-31 | 一种提高免疫力的黄精保健茶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103719498B (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104206597B (zh) * | 2014-09-05 | 2016-08-24 | 杨高林 | 一种缓解肺肾阴虚症状的五味子保健茶及其制备方法 |
CN104365942A (zh) * | 2014-11-20 | 2015-02-25 | 青岛恒波仪器有限公司 | 一种桑葚清肝明目保健茶及其制备方法 |
CN104381537A (zh) * | 2014-11-21 | 2015-03-04 | 白杨 | 一种防治亚健康的保健茶 |
CN105192195A (zh) * | 2014-11-27 | 2015-12-30 | 青岛申达高新技术开发有限公司 | 一种抗疲劳的刺五加保健茶及其制备方法 |
CN104489172A (zh) * | 2014-11-27 | 2015-04-08 | 青岛申达高新技术开发有限公司 | 一种提高免疫力的刺五加保健茶及其制备方法 |
CN104605344A (zh) * | 2015-01-05 | 2015-05-13 | 江西汇仁药业有限公司 | 一种增强免疫力的保健食品及其制备方法 |
CN104938698A (zh) * | 2015-07-22 | 2015-09-30 | 李友元 | 一种养生茶及其制备方法 |
CN105076613A (zh) * | 2015-09-02 | 2015-11-25 | 淮安市中医院 | 芪术养生保健袋泡茶及其制备方法 |
CN105941773A (zh) * | 2016-07-14 | 2016-09-21 | 河北国金药业有限责任公司 | 一种保健茶及其应用 |
CN107865151A (zh) * | 2016-09-23 | 2018-04-03 | 北京利康绿色医药生物技术研究所 | 一种具有促进睡眠以及提高免疫力功能的石斛兰茉莉花茶及其制备方法 |
CN106344812A (zh) * | 2016-11-21 | 2017-01-25 | 冯祥柱 | 一种健身中药冲剂及其制备方法 |
CN107019136A (zh) * | 2017-05-26 | 2017-08-08 | 江苏耐雀生物工程技术有限公司 | 一种具有降血糖功效的固体饮料及其制备方法 |
CN107647017A (zh) * | 2017-09-25 | 2018-02-02 | 浙江达因生物科技有限公司 | 一种用于改善老年人疲倦乏力的黄精中草药茶饮品及其制备方法 |
CN108936654A (zh) * | 2018-06-12 | 2018-12-07 | 北京筑元吉康医药科技有限责任公司 | 一种增强免疫力的保健食品及其应用 |
CN109875044A (zh) * | 2019-05-07 | 2019-06-14 | 国科润泽(山东)特医膳食科技有限公司 | 复合增免疫营养食品配方及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1301062C (zh) * | 2004-02-20 | 2007-02-21 | 陈宝和 | 黄精茶及其生产方法 |
CN1274233C (zh) * | 2005-04-01 | 2006-09-13 | 赖高翔 | 黄精药茶及其制备方法 |
CN1895546B (zh) * | 2006-06-08 | 2010-05-26 | 李高霖 | 具有治疗和保健功能的枸杞多糖药物组合物 |
CN101342313B (zh) * | 2008-08-26 | 2010-12-01 | 长沙藏谷生物科技有限公司 | 一种保健颗粒剂及其制备方法和应用 |
CN101695545A (zh) * | 2009-08-25 | 2010-04-21 | 李永胜 | 一种抗衰老抗疲劳补充精气血的颗粒和胶囊 |
-
2013
- 2013-12-31 CN CN201310753121.9A patent/CN103719498B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103719498A (zh) | 2014-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103719498B (zh) | 一种提高免疫力的黄精保健茶及其制备方法 | |
CN102048933B (zh) | 一种治疗小儿腹泻的中药组合物及其制备方法 | |
CN103734428B (zh) | 一种提高免疫力的女贞子保健茶及其制备方法 | |
CN104435775A (zh) | 一种中药保健酒及其制备方法 | |
CN103734426B (zh) | 一种提高免疫力的山茱萸保健茶及其制备方法 | |
CN104338043B (zh) | 一种提高免疫力的药物及其制备方法 | |
CN103301413A (zh) | 一种治疗高血脂合并高血糖症的中药组合物 | |
CN104305205B (zh) | 一种提高免疫力的菟丝子口服液及其制备方法 | |
CN103719497A (zh) | 一种绞股蓝降脂减肥保健茶及其制备方法 | |
CN103719493B (zh) | 一种补脑益智的黄精保健茶及其制备方法 | |
CN103719491B (zh) | 一种黄精健脾润肺保健茶及其制备方法 | |
CN104365943A (zh) | 一种降糖降脂的槐角茶及其制备方法 | |
CN103749821B (zh) | 一种提高免疫力的绞股蓝保健茶及其制备方法 | |
CN103301267B (zh) | 一种治疗高血压和/或动脉粥样硬化的中药组合物及应用 | |
CN107412665B (zh) | 一种具有解酒、防治酒精性肝损伤的中药组合物及其制备方法和应用 | |
CN104223297B (zh) | 一种延缓衰老的五味子保健口服液及其制备方法 | |
CN104489172A (zh) | 一种提高免疫力的刺五加保健茶及其制备方法 | |
CN106177432A (zh) | 一种包含青钱柳叶、桑叶、绿茶和玉竹的保健组合物 | |
CN111919982A (zh) | 天然植物解酒饮料及其制备方法 | |
CN104474472A (zh) | 具有降三高作用的苦丁茶含片及其生产方法 | |
CN104206595A (zh) | 一种降脂降糖的地骨皮保健茶及其制备方法 | |
CN103749819A (zh) | 一种降糖降脂的山茱萸保健茶及其制备方法 | |
CN106215118A (zh) | 抗肿瘤的保健制剂及其制备方法 | |
CN104286864B (zh) | 一种提高免疫力的沙苑子口服液及其制备方法 | |
CN103705860B (zh) | 一种治疗婴幼儿黄疸的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151105 Address after: 266044 Shandong city of Qingdao province Chongqing District Road No. 27 Building No. 1 room 402, unit 2 Applicant after: Zhang Xuwei Address before: 266071 Shandong province Qingdao City Road No. 19 east red room unit 7 Applicant before: Qingdao Hengbo Instrument Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 542899 No. 25 Jianshe Middle Road, the Guangxi Zhuang Autonomous Region, Hezhou Patentee after: Zhang Xuwei Address before: 266044 Shandong city of Qingdao province Chongqing District Road No. 27 Building No. 1 room 402, unit 2 Patentee before: Zhang Xuwei |
|
TR01 | Transfer of patent right |
Effective date of registration: 20181220 Address after: 401120 Yubei District, Chongqing, Longxi street, Hong Jin Avenue 498, Jiale, Violet 1, 5- business. Patentee after: Chongqing Kai Tuo development in science and technology company limited Address before: 542899 No. 25 Jianzhong Road, Hezhou, the Guangxi Zhuang Autonomous Region. Patentee before: Zhang Xuwei |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190725 Address after: 102488 Building No. 1, Guohuai Street, Liangxiang, Fangshan District, Beijing - 105 Patentee after: Beijing Guangyao and biotech Co., Ltd. Address before: 401120 Jiale Ziguang Building 5-Business, 498 Hongjin Avenue, Longxi Street, Yubei District, Chongqing Patentee before: Chongqing Kai Tuo development in science and technology company limited |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190819 Address after: 100020 Building No. 12, Xidawang Road, Chaoyang District, Beijing (Incubator 27121, National Advertising Industry Park) Patentee after: Beijing Fengyisheng Biotechnology Co., Ltd. Address before: 102488 Building No. 1, Guohuai Street, Liangxiang, Fangshan District, Beijing - 105 Patentee before: Beijing Guangyao and biotech Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190925 Address after: 247100 Zhushan Formation, Lingtang Village, Qiaomu Township, Qingyang County, Chizhou City, Anhui Province Patentee after: Qingyang Fengchuang Biotechnology Co., Ltd. Address before: 100020 Building No. 12, Xidawang Road, Chaoyang District, Beijing (Incubator 27121, National Advertising Industry Park) Patentee before: Beijing Fengyisheng Biotechnology Co., Ltd. |
|
TR01 | Transfer of patent right |